BD | Better Buildings Initiative

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. BD has over 70,000 associates serving more than 190 countries, working with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

Collaboration and a mindset of continuous improvement are at the core of BD operations. BD applies lean and continuous improvement methodologies across the enterprise to drive efficiency and cost effectiveness.

BD has made three commitments as a participant in the Better Climate Challenge:

1. They have pledged to reduce GHG emissions by 50% by 2030 (against a 2019 baseline)

2. A 25% energy intensity reduction by 2030 (against a 2019 baseline)

3. Reduce water consumption by 40% by 2030 (against a 2019 baseline)

PORTFOLIO-WIDE LEADERSHIP COMMITMENTS

50% emissions reduction by 2030

25% reduction in energy intensity by 2030

40% reduction in water intensity by 2030

Showcase Project

Becton Dickinson: Torrey View Solar Project

Leadership Commitments

Better Plants Challenge

Goal

25% Reduction in Energy Intensity 25% reduction in Energy Intensity by 2030 across 49 manufacturing, distribution, and R&D sites in the US

Commitment

49 Facilities

Progress

11% Cumulative (vs. Baseline)

BD

Performance Data

Solutions

Leadership Commitments

Better Climate Challenge

Goal

Commitment

Better Plants Challenge

Goal

Commitment

Progress

Water Reduction

Goal

Progress

DOE Program Participation